择期经皮冠状动脉介入治疗中的抗血小板和抗凝治疗。
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention.
作者信息
ten Berg Jurriën M, Plokker HW Thijs, Verheugt Freek WA
机构信息
Department of Cardiology, St Antonius Hospital, Koekoekslaan 1, 3435 CM Nieuwegein, The Netherlands.
出版信息
Curr Control Trials Cardiovasc Med. 2001;2(3):129-140. doi: 10.1186/cvm-2-3-129.
Abstract
Thrombosis plays a major role in acute vessel closure both after coronary balloon angioplasty and after stenting. This review will address the role of antiplatelet and anticoagulant therapy in preventing early thrombotic complications after percutaneous coronary intervention. The focus will be on agents that are routinely available and commonly used.
摘要
血栓形成在冠状动脉球囊血管成形术和支架置入术后的急性血管闭塞中起主要作用。本综述将探讨抗血小板和抗凝治疗在预防经皮冠状动脉介入治疗后早期血栓形成并发症中的作用。重点将放在常规可用且常用的药物上。
相似文献
1
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention.
Curr Control Trials Cardiovasc Med. 2001;2(3):129-140. doi: 10.1186/cvm-2-3-129.
2
Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Am Heart J. 2004 May;147(5):815-22. doi: 10.1016/j.ahj.2003.11.025.
3
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.
N Engl J Med. 1996 Apr 25;334(17):1084-9. doi: 10.1056/NEJM199604253341702.
4
Current status and prospects of antiplatelet therapy in percutaneous coronary intervention in Japan: focus on adenosine diphosphate receptor inhibitors.
J Cardiol. 2011 Jul;58(1):6-17. doi: 10.1016/j.jjcc.2011.03.002. Epub 2011 Apr 29.
5
Antiplatelet and anticoagulant agents: key differences in mechanisms of action, clinical application, and therapeutic benefit in patients with non-ST-segment-elevation acute coronary syndromes.
Curr Opin Cardiol. 2008 Jul;23(4):302-8. doi: 10.1097/HCO.0b013e3283021ad9.
6
Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy.
Mayo Clin Proc. 2006 May;81(5):641-52. doi: 10.4065/81.5.641.
7
Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
Am Heart J. 2009 Nov;158(5):713-8. doi: 10.1016/j.ahj.2009.09.001.
8
Coronary stenting for unstable angina: predictors of 30-day and long-term clinical outcome.
Coron Artery Dis. 1999;10(2):81-8.
9
Antiplatelet therapy for elective coronary stenting: a moving target.
Semin Vasc Med. 2003 Nov;3(4):415-8. doi: 10.1055/s-2004-817690.
10
Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
Anesth Analg. 2008 Aug;107(2):552-69. doi: 10.1213/ane.0b013e3181732049.
引用本文的文献
1
An architecturally rational hemostat for rapid stopping of massive bleeding on anticoagulation therapy.
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2316170121. doi: 10.1073/pnas.2316170121. Epub 2024 Jan 22.
2
Guidance Molecules in Vascular Smooth Muscle.
Front Physiol. 2018 Sep 19;9:1311. doi: 10.3389/fphys.2018.01311. eCollection 2018.
3
Targeted thrombolysis strategies for neuroprotective effect.
Neural Regen Res. 2014 Jul 1;9(13):1316-22. doi: 10.4103/1673-5374.137580.
4
The effects of xuefu zhuyu and shengmai on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris after percutaneous coronary intervention: a randomised controlled clinical trial.
Evid Based Complement Alternat Med. 2013;2013:896467. doi: 10.1155/2013/896467. Epub 2013 May 8.
5
Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease.
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009581. doi: 10.1002/14651858.CD009581.pub2.
6
Systematic Review of Chinese Herbal Medicines for Preventing in-Stent Coronary Restenosis after Percutaneous Coronary Intervention.
Evid Based Complement Alternat Med. 2012;2012:253409. doi: 10.1155/2012/253409. Epub 2012 Feb 16.
7
Clopidogrel and coronary stents: risks and benefits.
Curr Atheroscler Rep. 2008 Aug;10(4):303-8. doi: 10.1007/s11883-008-0047-6.
本文引用的文献
1
Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).
Circulation. 2001 May 15;103(19):2332-5. doi: 10.1161/01.cir.103.19.2332.
2
Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.
Circulation. 2001 Apr 17;103(15):1967-71. doi: 10.1161/01.cir.103.15.1967.
3
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial.
Circulation. 2001 Mar 13;103(10):1403-9. doi: 10.1161/01.cir.103.10.1403.
4
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.
Circulation. 2001 Feb 20;103(7):961-6. doi: 10.1161/01.cir.103.7.961.
5
FDA approval of coronary-artery brachytherapy.
N Engl J Med. 2001 Jan 25;344(4):297-9. doi: 10.1056/NEJM200101253440410.
6
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.
N Engl J Med. 2001 Jan 25;344(4):250-6. doi: 10.1056/NEJM200101253440402.
7
Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris.
Circulation. 2001 Feb 6;103(5):658-63. doi: 10.1161/01.cir.103.5.658.
8
Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial.
Lancet. 2000 Dec 16;356(9247):2037-44. doi: 10.1016/S0140-6736(00)03400-0.
9
Immediate stent implantation versus conventional techniques for the treatment of abrupt vessel closure or symptomatic dissections after coronary balloon angioplasty.
Am Heart J. 2000 Nov;140(5):e26. doi: 10.1067/mhj.2000.110573.
10
Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Am Heart J. 2000 Sep;140(3):483-91. doi: 10.1067/mhj.2000.108825.
Zotero 插件